In this video, Dr. Morgans discusses the key points of her presentation, “Advanced disease: incorporating molecular markers and genomic studies into therapy,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting.
- Recent Updates in the Treatment of Non-metastatic Castration-Resistant Prostate Cancer
- FDA Clears Insightec’s MRI-Guided Sound Wave Technology to Treat Prostate Cancer
- 23andMe Gets FDA Clearance for Prostate Cancer Risk Test
- Men With Prostate Cancer Benefit From Practicing Yoga in the Perioperative Setting
- MRI: Can It Be Used to Plan Ablative Therapies?